Simpson Thacher Represents Initial Purchasers in US$176.8 Million Offering of Global Depositary Shares by Oneness Biotech
12.10.20
This is only gets display when printing
The Firm recently represented J.P. Morgan in connection with the $176.8 million offering of Global Depositary Shares by Oneness Biotech Co., Ltd. (“Oneness Biotech”). J.P. Morgan acted as the sole global coordinator and bookrunner.
Oneness Biotech is a leading biopharmaceutical company in Taiwan with the mission to fulfill medical needs by developing new drugs to treat chronic disorders in dermatology and immunology.
The Simpson Thacher team for the transaction included Yi Gao, Howie Farn and June Hu (Corporate); and John Creed and William Smolinski (Tax).